Clinical trials recruiting for Stage III NSCLC
Fewer than 3 recruiting trials found.
2
Recruiting trials
0
US states with sites
2
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 2 2
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Carboplatin | 1 |
| Cemiplimab | 1 |
| Cemiplimab (maintenance) | 1 |
| Chemoradiotherapy | 1 |
| Curative hypofractionated radiotherapy | 1 |
| Paclitaxel | 1 |
| Tislelizumab | 1 |
Self-screener
Recruiting trials
- Adjuvant Chemotherapy +/- Cemiplimab and Sequential Hypofractionated Radiotherapy in Unfit or Elderly Patients With Stage III Lung Cancer
- Neoadjuvant Chemo-immunotherapy for Stage III PD-L1 Positive Non-Small Cell Lung Cancer (NSCLC)
Related conditions
Trials recruiting for Stage III NSCLC often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Stage III NSCLC trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.